Key Highlights

• Teradyne (NASDAQ: TER) shares are recovering after a 14% weekly decline tied to AI overcapacity fears sparked by Meta's compute-sharing news.

• Goldman Sachs and BofA both raised or maintained bullish targets, at $465 and $525 respectively, framing the pullback as a buying opportunity.

• Record Q1 2026 revenue of $1.28 billion, up 87% year over year, underpins the more constructive analyst view.

Teradyne's sharp rebound this week has prompted a broader reassessment among Wall Street analysts of whether last week's steep decline represented a genuine buying opportunity rather than a warning sign about AI infrastructure demand.

The prior week's selloff was severe by any measure, with the stock shedding roughly 14%, including a single-session drop of 13.63% on July 2. That move was driven by broader chip sector fears that AI hyperscalers, particularly Meta, were monetizing excess compute capacity in a way that suggested potential demand softness across the AI buildout.

Goldman Sachs and Bank of America have both pushed back against that bearish interpretation. Goldman raised its price target to $465 from $350, while BofA maintained a Buy rating with a $525 target, with both firms citing an expanded total addressable market outlook tied to AI and data center demand.

Underpinning this more constructive view is Teradyne's underlying business performance. The company posted record first-quarter 2026 results, with revenue reaching $1.28 billion, up 87% year over year, driven in part by its growing role in AI chip testing through the UltraFLEXplus platform.

The gap between the prior week's sentiment-driven selloff and the fundamentals underlying Teradyne's business suggests the stock may serve as a useful test case for how investors distinguish between genuine demand deterioration and temporary sentiment shocks within the broader AI infrastructure trade.

As more hyperscalers report second-quarter results and capital spending plans in the coming weeks, Teradyne's ability to hold its rebound will offer a useful signal for how durable the broader AI infrastructure demand narrative proves to be across the semiconductor testing industry.

Semiconductor equipment names like Teradyne also tend to serve as a useful proxy for capital spending intentions across the chip industry more broadly, since testing equipment orders often provide an early read on production plans before they show up in end-market chip sales data.